Request for sample Copy@ https://www.kdmarketresearch.com/sample/3192
Continuous glucose monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. The embedded sensor measures the glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor for displaying the results. These systems play an integral role in diabetes management, owing to their associated several advantages over other glucose monitoring devices. Unlike conventional glucose monitors, these systems enable periodic monitoring of glucose levels, which is crucial for avoiding diabetic complications. In addition, CGMS technology has laid a roadmap to the most awaited, high-tech, closed-loop artificial/bionic pancreas. Therefore, development of novel and technologically advanced CGMS is the prime focus of glucose monitoring device manufacturing companies. It offers a wide range of applications for all age-cohorts, healthcare settings (diagnostic centers/clinics, hospital ICUs, and home healthcare), and geographies. Thus, CGMS market poses lucrative opportunity for both CGMS manufacturers and insulin pump manufacturers.
The global CGMS market generated $894 million in 2016, and is projected to reach $4,921 million by 2024, registering a CAGR of 22.9% during the forecast period. The pipeline of high-tech CGMS devices, such as smartphone-connected CGMS, wearable & smartphone-connected CGMS, non-invasive CGMS and ?smart? diabetes management solution (also called artificial/bionic pancreas), is expected to result in higher adoption of CGMS among endocrinologists and patients.
The market is categorized based on component, demographics, end user, and region. The CGMS components market includes durable components such as transmitters & receivers and integrated insulin pumps; and disposable components such as sensors. The segment for sensors occupies a dominant share in the CGMS market due to recurring sales of CGMS, short scrap life, and bulk purchases. Therefore, it is deployed in diagnostic centers/clinics. Moreover, the adoption of CGMS in hospital ICUs and in-home healthcare settings has increased in the recent years. On the basis of demographics, CGMS devices are categorized into child population (=14 years) and adult population (>14 years).
The report includes comprehensive geographical analysis and segmentation of geographical regions, which include North America, Europe, Asia-Pacific, and LAMEA. The major strategies adopted by market players are collaborations, product launches, and product approvals. The adoption of collaboration strategy by companies enables greater focus on innovation, distribution, and commercialization of devices.
KEY BENEFITS
> This report provides an extensive analysis of the current and emerging trends, and dynamics in the global CGMS market to identify the prevailing opportunities.
>It presents a competitive landscape of the global market to predict the market scenario across geographies.
>A comprehensive analysis of factors that drive and restrict the market growth is provided.
>The region- and country-wise analyses are provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
By Component
-Sensors
-Transmitters & Receivers
-Integrated Insulin Pumps
By Demographics
-Child Population (=14 years)
-Adult Population (>14 years)
By End User
-Diagnostics & Clinics
- ICUs
- Home Healthcare
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
-Italy
- Spain
- Netherlands
- Norway
- Sweden
- Denmark
- Finland
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
-Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Venezuela
- Argentina
- Rest of LAMEA
The key players profiled in this report are as follows:
- Abbott Laboratories
- Dexcom, Inc.
- A. Menarini Diagnostics
- Echo Therapeutics, Inc.
- GlySens Incorporated
- Johnson & Johnson
- Insulet Corporation
- Medtronic plc
- Senseonics Holdings, Inc.
- F. Hoffmann-La Roche Ltd.
Access Complete Research Report with toc@ https://www.kdmarketresearch.com/report/3192/continuous-glucose-monitoring-systems-market-amr
Table of Content
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits
1.3. Key Market Segments
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition
3.2. Need for glucose monitoring systems
3.2.1. Diabetes-a pandemic
3.2.1.1. Type 1 diabetes
3.2.1.2. Type-2 diabetes
3.2.1.3. Prediabetes and gestational diabetes mellitus (GDM)
3.2.1.4. Gestational diabetes mellitus (GDM)
3.2.1.5. Secondary diabetes
3.2.1.6. Global healthcare expenditure on diabetes
3.3. Key Findings
3.3.1. Top investment pockets
3.3.2. Top winning strategies
3.3.3. Value Chain Analysis
3.4. Patent analysis
3.4.1. Patent analysis, by market participant
3.4.2. U.S. patent analysis, by market participant
3.4.3. Patent analysis, by year
3.5. Market Share Analysis, 2017
3.6. Government Regulations
3.6.1. FDA regulations (21CFR820)
3.6.1.1. Objective and Scope of FDA 21CFR820
3.6.2. ISO regulations (ISO 13485:2003)
3.6.2.1. Objective and Scope of ISO 13485:2003
3.7. Reimbursement Scenario
3.8. Market dynamics
3.8.1. Drivers
3.8.1.1. Benefits of CGMS over POC glucometers
3.8.1.2. Rise in incidence of diabetes cases
3.8.1.3. Technological advancements
3.8.2. Restraints
3.8.2.1. Adverse effects and accuracy
3.8.2.2. Reimbursement and stringent regulatory issues
3.8.3. Opportunities
3.8.3.1. High adoption rate of CGMS in home healthcare and ICUs
3.8.3.2. Increase in product awareness
3.8.3.3. High undiagnosed patient population
3.8.4. Impact analyses
CHAPTER 4: CONTINOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT
4.1. Overview
4.1.1. Market size and forecast
4.2. Sensors
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Transmitters & Receivers
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. Integrated Insulin pumps
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
CHAPTER 5: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
5.1. Overview
5.1.1. Market size and forecast
5.2. Adult Population (>14 years)
5.2.1. Market size and forecast
5.3. Children Population (14 years)
5.3.1. Market size and forecast
CHAPTER 6: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Diagnostic centers/clinics
6.2.1. Market size and forecast
6.3. ICUs
6.3.1. Market size and forecast
6.4. Home Healthcare
6.4.1. Market size and forecast
CHAPTER 7: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America continuous glucose monitoring systems market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. continuous glucose monitoring systems market size and forecast, by component
7.2.2.1.2. U.S. continuous glucose monitoring systems market size and forecast, by demographics
7.2.2.1.3. U.S. continuous glucose monitoring systems market size and forecast, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada continuous glucose monitoring systems market size and forecast, by component
7.2.2.2.2. Canada continuous glucose monitoring systems market size and forecast, by demographics
7.2.2.2.3. Canada continuous glucose monitoring systems market size and forecast, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico continuous glucose monitoring systems market size and forecast, by component
7.2.2.3.2. Mexico continuous glucose monitoring systems market size and forecast, by demographics
7.2.2.3.3. Mexico continuous glucose monitoring systems market size and forecast, by end user
7.2.3. North America continuous glucose monitoring systems market size and forecast, by component
7.2.4. North America continuous glucose monitoring systems market size and forecast, by demographics
7.2.5. North America continuous glucose monitoring systems market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe continuous glucose monitoring systems market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany continuous glucose monitoring systems market size and forecast, by component
7.3.2.1.2. Germany continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.1.3. Germany continuous glucose monitoring systems market size and forecast, by end user
7.3.2.2. France
7.3.2.2.1. France continuous glucose monitoring systems market size and forecast, by component
7.3.2.2.2. France continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.2.3. France continuous glucose monitoring systems market size and forecast, by end user
7.3.2.3. UK
7.3.2.3.1. UK continuous glucose monitoring systems market size and forecast, by component
7.3.2.3.2. UK continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.3.3. UK continuous glucose monitoring systems market size and forecast, by end user
7.3.2.4. Spain
7.3.2.4.1. Spain continuous glucose monitoring systems market size and forecast, by component
7.3.2.4.2. Spain continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.4.3. Spain continuous glucose monitoring systems market size and forecast, by end user
7.3.2.5. Italy
7.3.2.5.1. Italy continuous glucose monitoring systems market size and forecast, by component
7.3.2.5.2. Italy continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.5.3. Italy continuous glucose monitoring systems market size and forecast, by end user
7.3.2.6. Netherlands
7.3.2.6.1. Netherlands continuous glucose monitoring systems market size and forecast, by component
7.3.2.6.2. Netherlands continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.6.3. Netherlands continuous glucose monitoring systems market size and forecast, by end user
7.3.2.7. Norway
7.3.2.7.1. Norway continuous glucose monitoring systems market size and forecast, by component
7.3.2.7.2. Norway continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.7.3. Norway continuous glucose monitoring systems market size and forecast, by end user
7.3.2.8. Sweden
7.3.2.8.1. Sweden continuous glucose monitoring systems market size and forecast, by component
7.3.2.8.2. Sweden continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.8.3. Sweden continuous glucose monitoring systems market size and forecast, by end user
7.3.2.9. Denmark
7.3.2.9.1. Denmark continuous glucose monitoring systems market size and forecast, by component
7.3.2.9.2. Denmark continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.9.3. Denmark continuous glucose monitoring systems market size and forecast, by end user
7.3.2.10. Finland
7.3.2.10.1. Finland continuous glucose monitoring systems market size and forecast, by component
7.3.2.10.2. Finland continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.10.3. Finland continuous glucose monitoring systems market size and forecast, by end user
7.3.2.11. Rest of Europe
7.3.2.11.1. Rest of Europe continuous glucose monitoring systems market size and forecast, by component
7.3.2.11.2. Rest of Europe continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.11.3. Rest of Europe continuous glucose monitoring systems market size and forecast, by end user
7.3.3. Europe continuous glucose monitoring systems market size and forecast, by component
7.3.4. Europe continuous glucose monitoring systems market size and forecast, by demographics
7.3.5. Europe continuous glucose monitoring systems market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific continuous glucose monitoring systems market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan continuous glucose monitoring systems market size and forecast, by component
7.4.2.1.2. Japan continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.1.3. Japan continuous glucose monitoring systems market size and forecast, by end user
7.4.2.2. China
7.4.2.2.1. China continuous glucose monitoring systems market size and forecast, by component
7.4.2.2.2. China continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.2.3. China continuous glucose monitoring systems market size and forecast, by end user
7.4.2.3. India
7.4.2.3.1. India continuous glucose monitoring systems market size and forecast, by component
7.4.2.3.2. India continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.3.3. India continuous glucose monitoring systems market size and forecast, by end user
7.4.2.4. Australia
7.4.2.4.1. Australia continuous glucose monitoring systems market size and forecast, by component
7.4.2.4.2. Australia continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.4.3. Australia continuous glucose monitoring systems market size and forecast, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea continuous glucose monitoring systems market size and forecast, by component
7.4.2.5.2. South Korea continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.5.3. South Korea continuous glucose monitoring systems market size and forecast, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific continuous glucose monitoring systems market size and forecast, by component
7.4.2.6.2. Rest of Asia-Pacific continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.6.3. Rest of Asia-Pacific continuous glucose monitoring systems market size and forecast, by end user
7.4.3. Asia-Pacific continuous glucose monitoring systems market size and forecast, by component
7.4.4. Asia-Pacific continuous glucose monitoring systems market size and forecast, by demographics
7.4.5. Asia-Pacific continuous glucose monitoring systems market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA continuous glucose monitoring systems market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil continuous glucose monitoring systems market size and forecast, by component
7.5.2.1.2. Brazil continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.1.3. Brazil continuous glucose monitoring systems market size and forecast, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia continuous glucose monitoring systems market size and forecast, by component
7.5.2.2.2. Saudi Arabia continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.2.3. Saudi Arabia continuous glucose monitoring systems market size and forecast, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Africa continuous glucose monitoring systems market size and forecast, by component
7.5.2.3.2. South Africa continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.3.3. South Africa continuous glucose monitoring systems market size and forecast, by end user
7.5.2.4. Venezuela
7.5.2.4.1. Venezuela continuous glucose monitoring systems market size and forecast, by component
7.5.2.4.2. Venezuela continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.4.3. Venezuela continuous glucose monitoring systems market size and forecast, by end user
7.5.2.5. Argentina
7.5.2.5.1. Argentina continuous glucose monitoring systems market size and forecast, by component
7.5.2.5.2. Argentina continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.5.3. Argentina continuous glucose monitoring systems market size and forecast, by end user
7.5.2.6. Rest of LAMEA
7.5.2.6.1. Rest of LAMEA continuous glucose monitoring systems market size and forecast, by component
7.5.2.6.2. Rest of LAMEA continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.6.3. Rest of LAMEA continuous glucose monitoring systems market size and forecast, by end user
7.5.3. LAMEA continuous glucose monitoring systems market size and forecast, by component
7.5.4. LAMEA continuous glucose monitoring systems market size and forecast, by demographics
7.5.5. LAMEA continuous glucose monitoring systems market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. Abbott Laboratories
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. A. Menarini Diagnostics S.r.l.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.3. DexCom, Inc.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.4. Echo Therapeutics, Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments
8.5. F. Hoffmann-La Roche Ltd.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. GlySens Incorporated
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Product portfolio
8.6.4. Key strategic moves and developments
8.7. Insulet Corporation
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Product portfolio
8.7.4. Business performance
8.7.5. Key strategic moves and developments
8.8. Johnson & Johnson
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments
8.9. Medtronic Plc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Senseonics Holdings, Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
Click for Exclusive Discount @ https://www.kdmarketresearch.com/discount/3192
About Us:
KD Market Research is one of the best market research organization that provides B2B research on the growth opportunities of the industry which is the prime factor of the overall revenue of the organization. We identify the pain points which our client is facing around revenue methods and provide them with a comprehensive database which helps them to make intelligent decisions that could ensure growth to the organization.
Our Services include market intelligence, competitive intelligence, and customized research. These research reports help the organizations to make quick and powerful decisions that make out highest growth in revenue.
Contact us -
KD Market Research
150 State Street, Albany,
New York, USA 12207
Website: www.kdmarketresearch.com
Email id- sales@kdmarketresearch.com
More - https://kdmarketresearch.blogspot.com/
No comments:
Post a Comment